Danielle Fink
Leidos (United States)(US)Frederick National Laboratory for Cancer Research(US)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Brain Metastases and Treatment, Immunodeficiency and Autoimmune Disorders, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → An immune-based biomarker signature is associated with mortality in COVID-19 patients(2020)365 cited
- → Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia(2009)327 cited
- → Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19(2022)249 cited
- → Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19(2021)238 cited
- → CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System(2015)198 cited
- → X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability(2017)172 cited
- → Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency(2016)114 cited
- → Interleukin-12 Receptor 1 Deficiency Predisposing to Disseminated Coccidioidomycosis(2011)98 cited
- → Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects(2019)80 cited
- → Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas(2021)59 cited